Chinese medical device company Tianxing Medical has submitted its listing application to the Hong Kong Stock Exchange for the second time. According to the preliminary prospectus, the joint sponsors for the company's listing are CITIC Securities and Jianyin International.

Tianxing Medical focuses on clinical solutions for sports medicine. According to data from ZhiShi Consulting, based on sales revenue in 2024, the company is the fourth largest provider of sports medicine equipment in China, with a market share of approximately 6.5% of the Chinese sports medicine implants and devices market, and is also the largest domestic provider of sports medicine equipment.

For the nine months ending in September last year, the company's revenue was approximately RMB 273 million, representing a year-on-year growth of 23.9%; net profit increased by 47.6% to RMB 89.872 million.

Tianxing Medical indicated that the net proceeds from this listing are intended to be used to expand production capacity and improve production efficiency; to support research and development work for patient-oriented product strategies; for commercialization, sales, and marketing activities; and for working capital and general corporate purposes